| P50 | author | Giuseppe Pantaleo | Q88061163 |
| | Alexandre Harari | Q43779462 |
| P2860 | cites work | CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 |
| | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 |
| | Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells | Q28215003 |
| | Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue | Q28216640 |
| | Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 |
| | GP120: target for neutralizing HIV-1 antibodies | Q28303124 |
| | Central memory and effector memory T cell subsets: function, generation, and maintenance | Q29615097 |
| | HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 |
| | Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody | Q29618366 |
| | Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 |
| | Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 | Q29619512 |
| | Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12 | Q30701127 |
| | The role of B cells in acute and chronic infections | Q33664811 |
| | HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. | Q33772204 |
| | Dissecting the host response to a gamma-herpesvirus | Q33772250 |
| | Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. | Q33810971 |
| | Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques | Q33843308 |
| | Accessing complexity: the dynamics of virus-specific T cell responses. | Q33932737 |
| | Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells | Q33981572 |
| | Viral mechanisms of immune evasion | Q34011092 |
| | Skewed maturation of memory HIV-specific CD8 T lymphocytes | Q45284555 |
| | IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity | Q45669191 |
| | Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy | Q45721932 |
| | Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections | Q45733084 |
| | Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors | Q45747345 |
| | HIV vaccine design and the neutralizing antibody problem | Q46474020 |
| | The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration | Q47643908 |
| | HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. | Q50752944 |
| | Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function. | Q51024682 |
| | Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. | Q51995303 |
| | Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. | Q52004225 |
| | Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. | Q52008553 |
| | Immune control of HIV-1 after early treatment of acute infection | Q56961920 |
| | Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies | Q57226425 |
| | CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 |
| | Escape from the immune system | Q59090018 |
| | On immunological memory | Q71284608 |
| | Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection | Q77386243 |
| | HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors | Q78342521 |
| | Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation | Q79213173 |
| | HIV vaccines | Q82900063 |
| | Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. | Q34060144 |
| | The dynamics of the cellular immune response to HIV infection: implications for vaccination | Q34143929 |
| | Neutralizing antiviral antibody responses | Q34419527 |
| | Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. | Q34468117 |
| | Immunologic control of HIV-1. | Q34511495 |
| | T cell memory | Q34542272 |
| | Effector and memory T-cell differentiation: implications for vaccine development | Q34632071 |
| | Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection | Q35020830 |
| | The Evolution of Antigen-Specific CD8+T Cell Responses after Natural Primary Infection of Humans with Epstein-Barr Virus | Q35119207 |
| | Kinetics of the immune response during HBV and HCV infection. | Q35164171 |
| | Similarities and differences in CD4+ and CD8+ effector and memory T cell generation | Q35207085 |
| | Human CD8(+) T-cell differentiation in response to viruses | Q35597100 |
| | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load | Q35784804 |
| | Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection | Q35785225 |
| | Cytomegalovirus (CMV)-specific cellular immune responses. | Q35789364 |
| | HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function | Q35834664 |
| | Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know | Q35852348 |
| | Progress toward an HIV vaccine | Q36014700 |
| | Ex vivo analysis of T-cell function | Q36159944 |
| | T cells and viral persistence: lessons from diverse infections | Q36238129 |
| | Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. | Q36369035 |
| | HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity | Q36371562 |
| | Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. | Q36452614 |
| | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 | Q36474240 |
| | Functional signatures of protective antiviral T-cell immunity in human virus infections. | Q36529008 |
| | Progress and obstacles in the development of an AIDS vaccine | Q36662462 |
| | Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides | Q37422520 |
| | Immune responses during measles virus infection | Q40549692 |
| | Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. | Q40721814 |
| | A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. | Q40757568 |
| | Immune responses to varicella-zoster virus | Q41150938 |
| | A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. | Q41419602 |
| | Neutralizing antiviral B cell responses | Q41464284 |
| | Escape of human immunodeficiency virus from immune control | Q41464292 |
| | Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization | Q41478638 |
| | Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 |
| | HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression | Q43750477 |
| | Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load | Q43779427 |
| | Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population | Q44933069 |
| P304 | page(s) | 75-92 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Advances in Pharmacology | Q15753809 |
| P1476 | title | HIV-1-specific immune response | |
| P478 | volume | 56 | |